| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 13:17:45 UTC |
|---|
| Update Date | 2021-09-26 23:07:55 UTC |
|---|
| HMDB ID | HMDB0254131 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | Lixivaptan |
|---|
| Description | Lixivaptan, also known as VPA-985, belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. Based on a literature review a significant number of articles have been published on Lixivaptan. This compound has been identified in human blood as reported by (PMID: 31557052 ). Lixivaptan is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Lixivaptan is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1 InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33) |
|---|
| Synonyms | | Value | Source |
|---|
| 5-Fluoro-2-methyl-N-(4-(5H-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11H)-ylcarbonyl)-3-chlorophenyl)benzamide | HMDB | | N-4-(3-Chloro-4-(5H-pyrrolo(2,1-C)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide | HMDB | | VPA 985 | HMDB | | VPA-985 | HMDB | | WAY vpa-985 | HMDB | | WAY-vpa-985 | HMDB | | WAY-vpa-985CRTX 080 | HMDB | | VPA-985lixivaptan | HMDB |
|
|---|
| Chemical Formula | C27H21ClFN3O2 |
|---|
| Average Molecular Weight | 473.93 |
|---|
| Monoisotopic Molecular Weight | 473.1306328 |
|---|
| IUPAC Name | N-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide |
|---|
| Traditional Name | N-(3-chloro-4-{3,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl}phenyl)-5-fluoro-2-methylbenzamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=CC=C(F)C=C1C(=O)NC1=CC=C(C(=O)N2CC3=CC=CN3CC3=C2C=CC=C3)C(Cl)=C1 |
|---|
| InChI Identifier | InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33) |
|---|
| InChI Key | PPHTXRNHTVLQED-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzanilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with a benzene ring. They have the general structure RNC(=O)R', where R,R'= benzene. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Anilides |
|---|
| Direct Parent | Benzanilides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzanilide
- 1,4-benzodiazepine
- Benzodiazepine
- 2-halobenzoic acid or derivatives
- 3-halobenzoic acid or derivatives
- Halobenzoic acid or derivatives
- Benzamide
- O-toluamide
- Benzoic acid or derivatives
- Toluamide
- Benzoyl
- Halobenzene
- Toluene
- Fluorobenzene
- Chlorobenzene
- Aryl halide
- Aryl fluoride
- Aryl chloride
- Vinylogous halide
- Tertiary carboxylic acid amide
- Pyrrole
- Heteroaromatic compound
- Carboxamide group
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Organoheterocyclic compound
- Azacycle
- Organohalogen compound
- Organonitrogen compound
- Organooxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Organochloride
- Organofluoride
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 18.1467 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 0.95 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3047.0 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 405.3 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 235.8 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 210.1 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 162.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 787.9 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 799.8 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 90.0 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1693.2 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 579.9 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1853.6 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 548.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 461.2 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 287.3 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 242.1 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Lixivaptan,1TMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C | 3842.8 | Semi standard non polar | 33892256 | | Lixivaptan,1TMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C | 3605.5 | Standard non polar | 33892256 | | Lixivaptan,1TMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C | 4740.2 | Standard polar | 33892256 | | Lixivaptan,1TBDMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C | 4059.1 | Semi standard non polar | 33892256 | | Lixivaptan,1TBDMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C | 3809.7 | Standard non polar | 33892256 | | Lixivaptan,1TBDMS,isomer #1 | CC1=CC=C(F)C=C1C(=O)N(C1=CC=C(C(=O)N2CC3=CC=CN3CC3=CC=CC=C32)C(Cl)=C1)[Si](C)(C)C(C)(C)C | 4761.6 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Lixivaptan GC-MS (Non-derivatized) - 70eV, Positive | splash10-002u-9500000000-0bda8b4d08dc950c0569 | 2021-09-23 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Lixivaptan GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 10V, Positive-QTOF | splash10-00di-0110900000-55d50135d5b975506810 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 20V, Positive-QTOF | splash10-000l-0930400000-e3a6a773b6bfa9411cdb | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 40V, Positive-QTOF | splash10-0f79-4930000000-c39675e8fa3fde0d7b71 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 10V, Negative-QTOF | splash10-00di-0000900000-ad1882cf9c7594432338 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 20V, Negative-QTOF | splash10-00di-0402900000-c0299a543c627c5bf9b6 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 40V, Negative-QTOF | splash10-053r-0901000000-3a4fa230b6ad4b25c97d | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 10V, Positive-QTOF | splash10-00di-0000900000-8d3d3c414912f96d5d1e | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 20V, Positive-QTOF | splash10-00dr-0400900000-2c694bde24a438ac5abe | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 40V, Positive-QTOF | splash10-0pir-3900200000-77364acf67a34b244dcd | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 10V, Negative-QTOF | splash10-00di-0000900000-c8865dcac70cb7ee611d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 20V, Negative-QTOF | splash10-00di-0102900000-f3555a98de2acff1704c | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Lixivaptan 40V, Negative-QTOF | splash10-001i-3900000000-19d65f8dd1284a8c794d | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|